Medical researchers struggle to navigate conflicting regulatory frameworks when conducting transgender healthcare studies

Medical researchers face significant uncertainty and operational delays when designing studies related to transgender healthcare due to rapidly changing and inconsistent legislation across jurisdictions. Current solutions fail because researchers lack clear guidance on compliance requirements, ethical review processes differ by region, and institutional review boards (IRBs) struggle to keep pace with legislative changes, forcing researchers to pause or abandon valuable research projects.